About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETED

Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer

NCT02855281•Wissenschaftliches Institut Bethanien e.V

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Lung Neoplasms

Locations

1

Germany

Locations (1)

Wissenschaftliches Institut Bethanien e. V.

Solingen, North Rhine-Westphalia, Germany

Key Dates

Start Date

October 1, 2016

Primary Completion Date

December 1, 2018

Completion Date

December 1, 2018

Last Updated

March 5, 2021

Related Studies

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

NCT07143110

RECRUITINGPhase 1

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

NCT06885697

MesotheliomaNeoplasms+6 more

Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

NCT04577599

Lung NeoplasmsLung Cancer

RECRUITINGPhase 2

Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

NCT06974604

Breast NeoplasmsLung Neoplasms

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

NCT07035587

Lung NeoplasmsPancreatic Neoplasms+6 more

Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC

NCT04631770

Lung NeoplasmsLymph Node Excision

View all related studies

Sponsors

Lead Sponsor

Wissenschaftliches Institut Bethanien e.V

Collaborators

Merck Sharp & Dohme LLC
Heinrich-Heine University, Duesseldorf

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions